Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Unknown 3

Sponsor Class

OTHER 28INDUSTRY 8OTHER_GOV 3NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 6Adenocarcinoma of Lung 3Meningeal Carcinomatosis 2Lung Neoplasms 2Non-squamous Non-small Cell Lung Cancer 1Non-squamous Cell Non-Small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Pemetrexed 3Gefitinib 2Carboplatin 2icotinib 1endostar protein 1apatinib 1Platinum Compounds 1Endostatins 1Drug Therapy 1Cisplatin 1Bevacizumab 1Berberine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Adenocarcinoma of Lung × Pemetrexed × Clear all
NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Henan Cancer Hospital

Phase 2 Unknown
60 enrolled
Thoracic

Adenocarcinoma of Lung

NCT03376737 2017-12-18

Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

Henan Cancer Hospital

Phase 2 Unknown
120 enrolled
Thoracic

Adenocarcinoma of Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡